四烯甲萘醌

Menatetrenone

未知生产厂商

Menatetrenone is a form of vitamin K2 which is used in the treatment of osteoporosis to stimulate osteogenesis.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Menatetrenone is a form of vitamin K2 which is used in the treatment of osteoporosis to stimulate osteogenesis.

适用于骨质疏松症的骨量和疼痛的改善。

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Preventive agent for carcinogenesis of liver cancer containing quinone-based compound as active ingredient
US 2007155841 A1申请人: OSAKA IND PROMOTION ORG优先权: 2004
CN
EP
US
3 件公开
Quinone-based therapeutic agent for hepatopathy
US 7138433 B2申请人: EISAI CO LTD优先权: 2003
US
2 件公开
Pharmaceutical Composition for Treatment or Prevention of Liver Cancer
US 2010292186 A1申请人: UNIV NAGOYA NAT UNIV CORP优先权: 2006
US
Menatetrenone soft capsule and preparation method thereof
- CN 101467983 B
  申请人: TIANJIN KANGHONG PHARMACEUTICAL TECHNOLOGY DEV CO LTD优先权: 2007
  CN
- CN 103655510 A
  申请人: CSPC NBP PHARMACEUTICAL CO LTD优先权: 2012
  CN
DOSING REGIMENS AND METHODS FOR TREATING OR PREVENTING HEPATOCELLULAR CARCINOMA
US 2012309744 A1申请人: NEUSTADT JOHN优先权: 2011
US
DOSING REGIMENS AND METHODS FOR TREATING OR PREVENTING ACUTE MYELOID LEUKEMIA
US 2012309845 A1申请人: NEUSTADT JOHN优先权: 2011
US
DOSING REGIMENS AND METHODS FOR TREATING OR PREVENTING MYELODYSPLASTIC SYNDROME
US 2012309846 A1申请人: NEUSTADT JOHN优先权: 2011
US
DOSING REGIMENS AND METHODS FOR TREATING OR PREVENTING PROMYELOCYTIC LEUKEMIA
US 2012309847 A1申请人: NEUSTADT JOHN优先权: 2011
US
Cathepsin K inhibitor containing naphthoquinone and phenanthrenequinone structures, composition and application thereof
CN 112294958 A申请人: SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL & PREVENTION优先权: 2020
CN